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Nicholas Frederick Downing 
CONTRIBUTIONS OF ANGIOMOTIN-LIKE-1 ON ASTROCYTIC MORPHOLOGY: 
POTENTIAL ROLES IN REGULATING CONNEXIN-43-BASED ASTROCYTIC 
GAP JUNCTIONS, REMODELING THE ACTIN CYTOSKELETON AND 
INFLUENCING CELLULAR POLARITY 
Glioblastoma is a lethal cancer that arises from support cells in the nervous system 
and kills around 20,000 people in the United States each year. While much is known about 
the highly malignant primary glioblastoma, the natural history of lower grade glioma 
(LGG) is less understood. While the majority of LGGs are initiated by a mutation in 
isocitrate dehydrogenase, the events leading to their malignant progression into a grade IV 
tumor are not known. Analysis of primary tumor sample data has revealed that low 
transcript levels of Angiomotin-like-1 (AmotL1) strongly associate with poor outcomes of 
patients with these cancers. Follow-up RNA-sequencing of human embryonic astrocytes 
with AmotL1 silencing revealed the downregulation of many transcripts that encode 
proteins mediating gap junctions (GJ) between astrocytes, especially connexin-43 (Cx43). 
Cx43 protein oligomerizes to form functional channels comprising the astrocytic GJ. 
AmotL1 knockdown through RNA interference decreases Cx43 transcript and protein 
levels while increasing its distribution to GJs. This suggests increased GJ formation and 
intercellular communication, as similar localization patterns are observed in differentiated 
astrocytes. Astrocytes with AmotL1 knockdown also display a pronounced pancake-like 
morphology, suggesting that the actin cytoskeleton is affected. Imaging reveals that cells 
with reduced AmotL1 have characteristic losses in both stress fibers and focal actin under 
the cell body but notable increases in cortical F-actin. Consistent with previous studies, 
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AmotL1 may promote increases in the number and thickness of F-actin fibers. Because 
actin binding to related angiomotins is inhibited by phosphorylation from the LATs 
kinases, I define the effects of expressing wildtype AmotL1 versus mutants that mimic or 
prevent phosphorylation by LATs1/2. Interestingly, expression of AmotL1 S262D in 
combination with NEDD4-1, a ubiquitin ligase, results in a profound loss of actin stress 
fibers. Dependence on NEDD4-1 suggests that this phenotype is due to the induced 
degradation of proteins that promote F-actin, e.g. RhoA. These results directly support a 
model in which phosphorylated AmotL1 specifically inhibits F-actin formation as opposed 
to unphosphorylated AmotL1 which is known to promote stress fiber formation. Thus, in 
addition to regulating polarity and YAP/TAZ transcriptional co-activators, AmotL1 plays 
major functions in dictating cellular F-actin dynamics. 
Clark D. Wells, PhD, Chair 
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Introduction 
According to the National Cancer Institute (NCI), an estimated 23,000 Americans are 
diagnosed with cancer of the central nervous system each year. Of these, at least 11,500 
are glioblastoma multiforme (GBM), gliomas that arise from abnormal changes in healthy 
glial cells (AANS, ABTA). For adults diagnosed with primary GBM, the estimated median 
survival is between one and three years depending on the genetic makeup of the tumor. 
This is because GBM initially presents as aggressive grade IV tumors (Davis 2016, 
Llaguno et al. 2016, ABTA). Although GBM can occur in individuals of all ages, the 
median age of onset is 67 years. A second type of glioma presents as a lower grade glioma 
(LGG). Unfortunately, many of these tumors go undiagnosed in patients until there is a 
manifestation of physical symptoms, such as intense headaches, nausea, blurred vision, 
changes in memory, sensation, balance and motor skills. These symptoms arise from brain 
swelling, due either to edema or from the pressure of the expanding tumor within the skull 
(Faivre et al. 2015). While these tumors initially present as grade II or grade III, after 
prolonged development, they progress into secondary grade IV tumors with a very poor 
patient prognosis. Grade II tumors are slow-growing and do not warrant immediate fear; 
with consistent monitoring and treatment, patients can be expected to have several years of 
high-quality life. Upon reaching grades III and IV, tumor cells de-differentiate, divide 
rapidly and become metastatic, invading other healthy tissues throughout the central 
nervous system (NCI). 
 The majority of lower grade gliomas contain a mutation in the isocitrate 
dehydrogenase 1 (IDH1) gene. Tumors with mutant IDH1 have an attenuated immune 
response and reduced tumor aggressiveness relative to tumors with wildtype (WT) IDH1 
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(Amankuloar et al. 2017). The IDH1 mutation which is detectable after surgical biopsy, 
has become a significant molecular marker in determining patient prognosis as individuals 
with mutant IDH1-positive tumors have a median survival of 29 months compared to those 
with WT IDH1, whose median survival is 13 months (ABTA). Additional work has 
revealed that mutant IDH1 has a neomorphic enzymatic activity that converts alpha-
ketoglutarate to the oncometabolite: 2-hydroxyglutarate (2-HG) (Molenaar et al. 2018, 
Sulkowski et al. 2017). Accumulation of 2-HG results in the inhibition of about 70 
intracellular dioxygenases that include TET DNA demethylases, Jumanji histone 
demethylases and EGLN prolyl hydroxylases resulting in negative consequences (Figueroa 
et al. 2010, Kickingereder et al. 2015). Excessive DNA methylation and HIF activation by 
an absence of prolyl hydroxylation are linked to secondary glioblastomas and to the 
progression of many tumor types, respectively (Kaur et al. 2005). 
 In recent years, the Wells laboratory has studied the role of a loss of angiomotin-
like 1 (AmotL1) in the progression of lower grade gliomas into secondary glioblastomas. 
Analysis of publicly-available tumor datasets (TCGA and Rembrandt) reveals that this loss 
of AmotL1 may be a significant factor in promoting malignant progression. AmotL1 is a 
scaffolding protein that binds apical polarity proteins through its C-terminus and the 
YAP/TAZ transcriptional co-activators at its N-terminus (Chan et al. 2011). This allows 
AmotL1 to control polarity and HIPPO signaling in a zero-sum manner to promote polarity 
and prevent cellular growth (Wang et al. 2010). The inhibition of YAP1 occurs through 
both sequestration in the cytosol and induced degradation. This inhibition prevents YAP1 
from entering the nucleus, thereby preventing the transcription of pro-growth and anti-
apoptotic genes (Zanconato et al. 2016). As one would expect, AmotL1 is frequently lost 
3 
in these cancers. Follow-up cell-based studies reveal that AmotL1 silencing results in 
offering the growth advantages that are associated with tumorigenesis (Huang et al. 2018). 
A subsequent step into this investigation was to identify any other genes or transcripts that 
are differentially expressed because of the absence of AmotL1. 
Using immortalized human embryonic astrocytes (hEATs), the laboratory silenced 
AmotL1 through lentiviral RNA interference (RNAi) and conducted RNA-seq on purified 
lysates prior to my admission. This analysis revealed drastic changes on transcript 
expression in a number of gap junction proteins. Remarkably, connexin-43 (Cx43) mRNA 
was downregulated, with a nearly 16-fold decrease relative to control cells (see Figure 1). 
Because Cx43 is essential for inter-astrocytic connections that are essential features in 
astrocyte differentiation, the loss of Cx43 is predicted to be a major event in cellular de-
differentiation. For this reason, I sought to determine how a loss of Cx43 upon silencing of 
AmotL1 may promote cancer phenotypes. 
Figure 1: RNA-seq analysis of AmotL1-silenced hEAT cells. Shown across the heat map are gap junction 
transcripts identified from online databases that present the most differential expression upon RNAi against 
AmotL1. Most notable is the significant downregulation Cx43 mRNA. I did not conduct this analysis, nor 
did I create this figure, but it played a major role in establishing the direction of my research. 
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An Overview of Cx43 and Gap Junctions 
Cells transmit small molecules between each other to relay information by Gap Junction 
Intercellular Communication (GJIC), to share metabolites or to offload toxic materials. 
Cell-cell contacts at gap junctions offer cells the opportunity to exchange signals directly 
between their cytoplasm. Astrocytes, as support cells in the brain, rely heavily on gap 
junctions as their primary sites of intercellular contact and to carry out their core functions 
of transferring nutrients, absorbing toxic materials and relaying signals. Specifically, gap 
junctions allow the free diffusion of small molecules and ions, under one kilodalton in size, 
from one cell to another through narrow, water-filled channels contained within gap 
junctions (Beyer et al. 2019, Mayor 2015, Lathia et al. 2015, Laird 2006). Gap junctions 
themselves are specialized structures composed of a network of connexins (Beyer et al. 
2019). These polypeptides are a highly diverse family of twenty-one known gap junction 
proteins, ranging in size from 23 to 62 kDa and named accordingly. Despite their 
differences, connexins all have highly conserved structures.  
 Connexins fold into four-pass transmembrane proteins with cytoplasmic N- and C-
termini, two extracellular loops, and one intracellular loop (See Figure 2, Kotini and Mayor 
2015, Laird 2006). Connexin monomers have a high affinity for oligomerization before 
arriving at the plasma membrane. It has been suggested that these polypeptides begin their 
association upon folding within the endoplasmic reticulum and continue progressively 
throughout the trans-Golgi network (Laird 2006). Six individual connexins oligomerize to 
form hexameric cylindrical structures known as hemichannels, or connexons. These 
complexes operate as pores in the membrane that can be selectively opened or closed by 
cellular stimuli, allowing for molecular transport into or out of a cell dependent of the 
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context (Yin et al. 2018). In addition to channel opening and closure, cells can regulate 
Figure 2: Formation of cellular gap junctions and functional interactions between Cx43, ZO-1 and F-actin. 
A. Generalized structure of a connexin protein. Each connexin has four transmembrane domains, two 
extracellular loops, one intracellular loop and cytoplasmic N- and C-termini. B. Formation of a hemichannel, 
or connexon. Six connexin proteins can oligomerize to form a hexameric structure, known as a hemichannel. 
These complexes connects the inside of a cell to the extracellular matrix (ECM) and allow for the import or 
export of small molecules and ions. C. Formation of a gap junction. Two hemichannels from adjacent cells 
can align and dock to one another, forming a gap junction channel. This gap junction directly connects the 
cytosol of two cells and allows for direct cell-cell communication through molecular transport. D. Interactions 
between the carboxyl-terminal tail of Cx43 and the second PDZ domain of ZO-1. ZO-1 serves as an actin-
binding protein, linking the actin cytoskeleton to Cx43 and the plasma membrane through its proline-rich 
carboxyl-terminal tail. Adapted from illustrations by Laird (2006), Wu and Wang (2019). 
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their GJIC by changing the expression of connexins. This can be achieved in a variety of 
ways: the alteration of transcription of connexin genes, such as GJA1 that encodes Cx43, 
changing the rates of connexin protein degradation and assembly or by influencing factors 
associated with any of these processes (Laird 2006).  
Single hemichannels allow for the molecular transport between a cell’s cytoplasm 
and the surrounding extracellular matrix (ECM); whereas, two opposing hemichannels 
from adjacent cells can align end-to-end and bind to form a complete gap junction. This 
effectively connects their cytosols and allows direct cell-cell communication. Docking is 
achieved through the formation of disulfide bonds between cysteine residues found in the 
extracellular loops of each connexin subunit of a hemichannel (Kotini and Mayor 2015). 
Although single gap junctions can form and become active, plaques are frequently 
observed between cells, appearing as a punctate assemblies of multiple gap junctions 
(Bukasukas et al. 2000). Pulse-chase experiments have identified that newly-formed Cx43-
based gap junctions form on the outside of these plaques and that older junctions are 
localized to the centers where they undergo internalization and eventual degradation by 
either, or both, the lysosome and 26S proteasome (Gaietta et al. 2002, Laing and Breyer 
1995, Leithe and Rivedal 2004, Laing et al. 1997). Connexins themselves, even as 
constituents of oligomers, have short half-lives of only several hours before they are 
degraded. As mentioned, this is likely due to the physiological pressures and necessities in 
GJIC that face the cell (Laird 2006).  
Cx43 is the most abundant connexin isoform in the central nervous system and is 
amongst the most studied in cancer; thus, the results from RNA-seq analysis showing a 
loss of Cx43 was speculated to be highly important for changes in cellular behavior (see 
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Figure 1). I therefore sought to understand the impact of reduced AmotL1 on Cx43 
localization in astrocytes. The expectation was that reduced Cx43 protein would inhibit 
gap junction formation and thereby reduce GJIC. Without GJIC, astrocytes lose cues that 
guide cellular polarity, and may ultimately assume invasive mesenchymal morphologies. 
Using AmotL1-silenced cells, I sought to define key mechanistic elements for the 
regulation of Cx43 that could, in turn, explain the proximal mechanisms that eventually 
drive the malignant phenotypes observed in the progression of GBM. 
Tumor-Suppressive Roles of Cx43 in Carcinogenesis 
Throughout the literature there has been extensive speculation of the putative roles of Cx43 
loss in cancer. It is established that GJIC is commonly lost in both dividing and cancer 
cells, due to changes in connexin expression and cellular localization (Wu 2019). 
Figure 3: AmotL1 knockdown changes morphology in A172 human GBM cell lines. Provided are images 
of A172 cell growth in a three-dimensional Matrigel matrix at various time points. (Bottom) Cells infected 
with a lentivirus producing shRNAs against AmotL1. These cells experience a knockdown of AmotL1 
through RNAi (Western blot analysis unavailable). (Top) Infected cells producing a negative control 
Scramble shRNA. At extended time points (12 hr, 48 hr), AmotL1-knockdown cells appear elongated and 
mesenchymal, suggestive of an invasive morphology. Control cells remain dendritic in their morphology. 
These images were taken by the Wells lab prior to my admission; I did not generate this figure. 
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Downregulation of Cx43, both at the transcript and protein level, has also been shown to 
lead to a loss of gap junction formation. Likewise, a re-localization of Cx43 from cortical 
membranes to cytoplasmic compartments reduces the formation of gap junctions and 
lowers the overall amount of GJIC. However, Cx43 has been shown to demonstrate both 
tumor-suppressive and oncogenic functions. 
 Many connexins at the cellular cortex, including Cx43, can bind -catenin to reduce 
the amount of -catenin available for nuclear translocation within the Wnt signaling 
pathway (Spagnol et al. 2018, Dianati et al. 2016). In normal cells, the Wnt signaling 
pathway is required for cell growth and proliferation (Komiya and Habas 2008). Wnt 
stimulatory factors act as ligands to bind the Frizzled receptor on the plasma membrane, 
leading to the cytoplasmic phosphorylation of the lipoprotein receptor-related protein 
(LRP). This active LRP binds to a multi-protein complex containing -catenin, preventing 
the ubiquitination of -catenin by -TrCP and subsequent proteasomal degradation. -
catenin is then free to translocate into the nucleus and displace the Groucho inhibitor from 
the TCF transcription factor (Macdonald et al. 2009). This permits the transcription of 
genes that promote growth and proliferation. Therefore, the binding between Cx43 and -
catenin produces tumor suppressive effects by inhibiting Wnt signaling including: 
decreased growth, proliferation and reduced expression of Bcl-2 anti-apoptotic regulators, 
resulting in increased cell death (Polakis 2012). 
 Overexpression of Cx43 in LH7 lung cancer and HT29 colon cancer cells results in 
reduced proliferation of both cancer types (Sirnes et al. 2012, Xu et al. 2008). Thus, reduced 
levels of Cx43 upon a loss of AmotL1 proteins is predicted to have oncogenic effects. In 
part, this may occur via the freeing of -catenin to stimulate expression of Wnt target genes. 
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For instance, increased expression of the antiapoptotic Bcl-2 regulator would increase the 
rate of cellular proliferation and inhibit apoptosis (Campbell and Tait 2018). In addition to 
inhibiting -catenin, Cx43 may inhibit cancer by playing a pivotal role in establishing cell 
polarity. In both breast cancer and glioma cells, overexpression of Cx43 shifts cells from a 
mesenchymal to epithelial phenotypes (Lin et al. 2002, McLachlan et al. 2006). This 
supports my prediction that a loss of Cx43 may lead to mesenchymal morphologies in 
astrocytes and potentially increased invasiveness. 
 Cx43-containing gap junctions promote polarity by mediating cell-cell cohesion 
through their extracellular cysteine residues as well as adhesion to ECM (Wu 2019). 
Downregulation of Cx43 reduces GJIC in U251 glioma cells and leads to increased motility 
in a wound-healing assay. However, Cx43 downregulation impairs invasion in a transwell 
assay (Strale et al. 2011). Upon expression of exogenous connexin proteins, glioma cells 
have demonstrated increased adhesiveness to extracellular surfaces in vitro (Lin et al. 
2002). These observations suggest that a loss of Cx43 would lead to both reduced GJIC 
and cohesion, events that are both associated with invasive phenotypes characteristic of 
metastatic cells. 
 Evidence also supports a tumor-promoting role for Cx43 in gastric, prostate and 
melanoma tumors that have increased levels of Cx43 mRNA and protein. The consequent 
increased cohesion between cancer cells and healthy cells as well as enhanced GJIC, 
promotes migration and invasion in vitro (Lamiche et al. 2011). Similar observations have 
been made in C6, GL15 and 8-MG glioma cells (Oliveira et al. 2005). Since Cx43 function 
in carcinogenesis is likely to be cell-specific, a deeper investigation in this human 
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embryonic astrocyte system is warranted to understand the impact of its loss upon AmotL1 
suppression. 
ZO-1 as a Cx43- and Actin-Binding Partner 
Due to the difficulties of imaging Cx43, even following antibody optimization and different 
cell-culturing conditions, the tight junction protein zona occludens-1 (ZO-1) was imaged 
to ascertain the degree of cell-cell contacts. ZO-1 is a 220 kDa scaffolding protein that 
contains several domains supporting protein-protein interactions, including three PDZ 
domains, a Src-homology 3 (SH3) domain, and a guanylate kinase homology domain 
(GUK) (see Figure 2; Giepmans and Moolenaar 1998, Laing et al. 2005). As a peripheral 
membrane protein, it binds directly to both the actin cytoskeleton, through its proline-rich 
C-terminus, and junctional proteins present in the plasma membrane, including Cx43. 
Structural and functional mutation studies have shown that the second PDZ domain of ZO-
1 binds the C-terminus of Cx43 between amino acids Q263 to the terminal I382 (Sorgen et 
al. 2004). 
Previous work from others finds prominent colocalization of ZO-1 and Cx43 
(Giepmans and Moolenaar 1998). However, ZO-1 is mainly detectable at the cellular 
peripheries and particularly at cell-cell contacts, unlike Cx43 which is found predominantly 
in the cell interior. ZO-1 localization therefore marks cell-cell contacts and is a marker of 
cytoskeletal changes responsible for establishing cellular polarity, morphology and 
direction in migration. 
Actin Dynamics in Guiding Cellular Polarity 
The actin cytoskeleton is a complex network of interlinking proteins that extend throughout 
the cell. Actin networks dictate the cellular architecture required for division, motility, 
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differentiation and polarity (Smyth et al. 2012, Tojkander et al. 2012). Often, abnormalities 
in the actin cytoskeleton or related proteins lead to the development of serious pathologies, 
including cancer. Actin filaments are polymers of actin, a highly globular 42 kDa protein 
that possesses inherent ATPase activity that increases upon polymerization. In the presence 
of high ATP levels, colliding monomers form a nucleus that undergoes elongation to form 
filamentous F-actin. Actin filaments themselves have polarity at their two distinct ends: a 
barbed (+) end that quickly accepts ATP-bound G-actin monomers for filament growth, 
and a pointed (-) end that is slow-growing. Actin filaments, as individual 8 nm thick 
strands, are weak and can easily be broken by mechanical forces; however, they can form 
much more stable complexes when bundled and cross-linked by actin-binding proteins. 
Actin stress fibers are dynamic, antiparallel bundles of actin filaments that are 
crosslinked by proteins such as α-actinin and filamin (Tojkander et al. 2012). Present in 
both motile and non-motile cells, stress-fibers serve critical roles in providing the 
contractility forces required for migration, morphogenesis and cellular adhesion. 
Frequently, stress fibers are anchored to focal adhesions, which are adhesive points of 
contact between the actin cytoskeleton and ECM, often found near the cell body. In 
migrating cells, new stress fibers and focal adhesions form towards the leading edge and 
provide adhesion to new surfaces. As this occurs, myosin-mediated contractions and the 
degradation of actin filaments in the trailing edge results in a loss of adhesion, allowing the 
cell to release from the ECM and move with the leading edge. Both focal adhesions and 
stress fibers have become of interest in understanding the observations that I have routinely 
made.  
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A consistent shift in astrocyte morphology upon knockdown of AmotL1 through 
RNAi is observed in which cells become more flattened and therefore occupy a greater 
cross-sectional area compared to controls. However, counter to expectations, AmotL1 
knockdown results in a loss of both stress fibers and focally-localized actin (See Figure 8). 
Instead, cortical actin is increased as is the distribution of ZO-1 to the cellular cortex. This 
matches the changes that promote polarity in intestinal epithelial cells. Upon activation and 
translocation of the LKB1 serine/threonine kinase to the cytoplasm following induction of 
STRAD, ZO-1 redistributes to the cell cortex (Baas et al. 2004). This is in response to actin 
cytoskeletal remodeling to form brush borders, a highly absorptive array of microvilli that 
cover the apical surfaces of intestinal cells. Considering cells grown on rigid surfaces 
develop more prominent stress fibers, my results are puzzling (Prager-Khoutorsky et al. 
2011). It is important to note that AmotL1-silenced cells retain adhesion to the ECM in 
vitro. The potential mechanisms and implication of this cytoskeletal rearrangement in the 
context of GBM is further discussed in the Results and Discussion. 
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Methods 
Cell Culture 
 Normal human embryonic astrocytes (hEAT) were grown in Dulbecco's Modified Eagle's 
Medium (DMEM)  (HyClone™, Logan, UT) supplemented with 10% fetal bovine serum 
(FBS, Biowest, Cat No: S1620), 1% Penicillin Streptomycin (5 mL at 100x; Gibcom™, 
REF: 10378-016), 0.0001% hydrocortisone, 0.0005% insulin, and 0.001% N-
acetylcysteine. Human glioblastoma (A-172) cells (American Type Culture Collection, 
Manassas, VA, A-172 [A172] (ATCC® CRL-1620™)) were grown in DMEM (HyClone™, 
Logan, UT) supplemented with 10% fetal bovine serum (FBS), 1% Penicillin-
Streptomycin. Transfectable human embryonic kidney cells (HEK293) were utilized for 
lentiviral production (293T (ATCC® CRL-3216™)). These were grown in DMEM 
(HyClone™, Logan, UT) supplemented with 10% FBS and 1% Penicillin-Streptomycin. 
All cells were maintained at 37oC with 5% CO2. Lentiviral-infected cell lines were cultured 
in each cell type’s respective complete media. To aid in adhesion, all hEAT cells were 
grown on collagen-coated plates. To induce differentiation, cells were seeded in plates and 
grown in 50% Barris Neurobasal® Medium supplemented with 1% Penicillin-
Streptomycin, 1% SATO medium, 0.001% N-acetylcysteine and 0.001% HBEGF for 60 
hours prior to collection. 
Bacterial Transformation and Plasmid Isolation  
Escherichia coli cell cultures were exposed to ampicillin-resistance-encoding plasmid 
constructs (pRRE, pVSV-G, pRSV-rev, and lentiviral: shAmotL1, shScramble, control-
YFP, AmotL1 WT-YFP, AmotL1 262D-YFP, AmotL1 262A-YFP, AIP4-mCherry, 
Nedd4-1-CFP) prior to heat-shock treatment for cell competency and DNA uptake. After 
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a 1 hour recovery incubation in Luria broth (LB), cells were plated onto LB agar plates 
with ampicillin and incubated at 37 oC overnight. The following day, isolated colonies were 
transferred to sterile flasks containing (1x) Yeast Extract Tryptone liquid microbial growth 
media and ampicillin. Beakers were placed on an orbital shaker overnight (250 rpm) at 
room temperature. After 16 hours, cell solutions were transferred to bottles for a 10-minute 
centrifugation at 6300 rpms. Supernatant was removed and cells were vortexed with a 
buffer enabling RNA hydrolysis upon lysis (50 mM Tris-Cl pH 8.0, 10 mM EDTA, 100 
ug/ml RNAse A). Once resuspended, cells were lysed using a detergent-containing buffer 
(200 mM NaOH, 1% SDS). Cells were exposed to a third buffer (3M potassium acetate 
and glacial acetic acid) that promotes macromolecular renaturation. Centrifugation was 
repeated under the same conditions and supernatant was filtered. Anion-exchange column 
chromatography was utilized to purify DNA. These samples were mixed with isopropanol 
and centrifuged at 13000 rpms for 10 minutes at 4 oC. Pelleted DNA was isolated, dried 
with 70% ethanol and resuspended in Tris-EDTA (TE) buffer.  
DNA Quantification 
DNA concentration and purity were quantified using an ND-1000 spectrophotometer 
V3.8.1 (NanoDrop®). Stock plasmid solutions were diluted to 500 ng/L in TE for use in 
transfection. 
Transfection of Transforming Cells 
Healthy 293T cells were plated onto 10 cm plates in complete media outlined above and 
incubated at 37oC with 5% CO2 for 24 hours prior to transfection. In polysterene tubes, 6 
g of pVSV-G, 5 g of pRSV-rev and 10 g of pRRE was added to serum-free DMEM as 
well as 20 g of desired lentiviral DNA. While vortexing, 25  L of polyethyleneimine 
15 
was added dropwise to each transfection mixture and left to incubate for 5 minutes at room 
temperature. Transfection mixtures were distributed evenly across each plate. After 4-18 
hour incubation at 37oC with 5% CO2, transfection media was replaced plates with 7 mL 
of fresh DMEM. Cells were left to incubate overnight at 37oC with 5% CO2. The following 
day, infection media was collected off each plate and stored at 4 oC (t1/2 = 2 weeks). 
Target Cell Infection 
For RNAi experiments, target cells (control hEAT, hEAT Cx43 Untagged, A172) were 
seeded at 500,000 cells per 10 cm plate and left to incubate 12-24 hours at 37oC with 5% 
CO2 prior to infection. After lentiviral media was collected following transfection of 293T 
cells, 1.95 mL solutions made up of 0.65 mL viral media and 1.3 mL complete media (1:4) 
were created and added to target cells. An additional 40 µL of polybrene were added to 
each plate and tilted to distribute evenly. To achieve RNAi, AmotL1 shRNA lentiviral 
vectors and shScramble negative control shRNA lentiviral vectors were synthesized prior 
to my entry into the Wells lab. The RNAi efficiency of AmotL1 shRNA was determined 
using Western blot. In later experiments looking at cytoskeletal dynamics under conditions 
with AmotL1 Control, AmotL1 WT, AmotL1 262D, AmotL1 262A +/- AIP4 or Nedd4-1, 
cells were seeded onto 6 cm plates at 200,000 cells/plate and incubated for 24 hours prior 
to infection. Cells were infected with 1 mL of virus (diluted 1:5 in media) at hours 24 and 
28 and media was replaced at hour 32. After an additional 24 hours of growth, cells were 
seeded onto coverslips and incubated at 37oC with 5% CO2 for 48 hours before fixation. 
Western Blot Analysis 
Protein concentrations were evaluated using the bicinchoninic acid assay (Thermo 
Scientific™, Pierce™ BCA Protein Assay Kit). 25-30 g of each lysate extract was 
16 
separated on 8% or 10% SDS polyacrylamide gels using electrophoresis at 160 Volts. The 
gel-separated proteins were transferred onto a nitrocellulose membrane using an 
orthogonal charge set to 24 V for 55 minutes. After blocking membranes with 5% non-fat 
milk powder solution overnight at 4oC, or on a rotator at room temperature for 20 minutes, 
membranes were probed using the following primary antibodies: overnight on nutator at 
4oC with rabbit-antihuman GAP-DH (1:1000), mouse-antihuman Cx43 (1:1000), mouse-
antihuman -tubulin (1:2000), or 2 hours with rabbit-antihuman AmotL1 (1:2000). The 
membranes were washed and incubated with secondary antibody for 30 minutes in dark on 
a rotator. Secondary antibodies include: goat anti-rabbit IRDye® 680 (1:20,000; Odyssey, 
827-08367), goat anti-mouse IRDye® 800CW (1:20,000; Odyssey, 827-08364). 
Membranes were analyzed using an Odyssey infrared imager (Li-Cor, USA). ImageJ 
software was used to quantify protein band intensities. 
Immunofluorescence 
Cells were plated onto acid-washed cover slips to improve adhesion. Media was removed 
after incubation and cells were washed twice with 1xPBS. They were fixed by incubating 
with 4% paraformaldehyde for 10 minutes. Fixed cells were washed twice and incubated 
for 30 minutes with blocking buffer (1xPBS supplemented with 5% bovine serum albumin 
(BSA), 0.002% saponin, and 100% 1000x NaN3 for bacterial and fungal inhibition). After 
incubation, cells were washed once and incubated for 1 hour at room temperature with 
antihuman monoclonal Cx43 Ab (1:400; Santa Cruz Biotechnology, sc-59949), polyclonal 
Cx43 Ab (1:400), monoclonal ZO-1 (1:1000), polyclonal AmotL1 (1:1500, made in 
house), monoclonal Arf6 (1:500; Santa Cruz Biotechnology, sc- 7971), monoclonal -
tubulin (1:1000; Developmental Studies Hybridoma Bank, AA4.3, AB_579793), or 
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monoclonal LAMP1 (1:400; Developmental Studies Hybridoma Bank, 1D4B, AB-
528127). After two washes, cells were incubated with secondary antibodies conjugated 
with AlexaFluor-488 (1:1000; Abcam), AlexaFluor-594 (1:1000; Santa Cruz), or 
phalloidin (1:3000; Santa Cruz, sc-363795) for 25 minutes. Afterwards, cells were washed 
twice. For nuclear staining, cells were incubated for 1 minute with 750 mL Hoechst 
solution (1:1000; 10 mg/mL). Coverslips were washed twice more in (1x) PBS and in 
deionized water before fixation to slides. Images and observations were performed using a 
Zeiss fluorescent microscope and AxioVision 4.8 software. Exposure times varied by 
antibody across treatments. 
Optimization of Primary Antibodies for Use in Immunofluorescence 
Prior to any experimental conditions, primary antibodies were applied to fixed cells at 
various dilutions to optimize staining and avoid the overuse of supplies. Attempted 
dilutions of each antibody are provided in parentheses and include: monoclonal Cx43 
(1:200, 1:400, 1:600), polyclonal Cx43 (1:200, 1:400, 1:600), monoclonal ZO-1 (1:600, 
1:800, 1:1000), polyclonal AmotL1 (1:250, 1:500, 1:750, 1:1000, 1:1500), monoclonal β-
tubulin (1:500, 1:1000), monoclonal Arf6 (1:500, 1:1000), monoclonal Lamp1 (1:200, 
1:400) and phalloidin (1:1000, 1:500, 1:2000, 1:2500, 1:3000). Images for each antibody 
dilution are included in Appendix A. 
Image Processing in AxioVision 
After capturing images in AxioVision 4.8, each was processed for optimal viewing 
conditions. Images captured using a Z-stack received a Z-stack Correction under the 
Processing and Adjust tabs, in which the parameters Correct Decay, Correct Flicker, and 
Correct Background were set to True. All images had Unsharp Masking applied to them 
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using the Sharpen feature. The parameters for Unsharp Masking were set as follows: Color 
Mode – RGB; Radius – 2; Strength – 1; Level Low – 0; Level High – 100; Threshold Mode 
– Binary; Auto Contrast – No; Auto Contrast Tolerance – 5; Clip To Valid Bits – Yes. Prior 
to export and Adobe editing, images could be optimized using the 
Brightness/Contrast/Gamma settings. 
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Results and Discussion 
Knockdown of AmotL1 reduces Cx43 protein expression yet causes an increase in its 
distribution to cell-cell contacts at potential gap junctions. 
Normal hEAT cells have low levels of Cx43 protein that are detectable by Western blot 
analysis. Therefore, an initial goal was to generate a cell line that stably overexpresses 
Cx43. According to RNA-seq data (Figure 1), a knockdown of AmotL1 is anticipated to 
result in a loss of Cx43 mRNA; I predicted that this would correlate with a reduction in 
Cx43 protein. Thus, to quantify global changes in Cx43 protein expression and to observe 
changes in Cx43 localization upon RNAi against AmotL1, I felt that it was essential to use 
a cell line that would not experience a complete loss of Cx43 protein. Shown below in 
Figure 4, I successfully generated a Cx43-overexpressing cell line via lentiviral infection, 
which I refer to as hEAT Cx43 Untagged throughout this thesis. With these cells, I sought 
to determine the effects of AmotL1 knockdown on Cx43. 
 Small inhibitory RNA (RNAi) has become a highly-utilized technique that 
introduces double-stranded RNA molecules to target a particular host mRNA for 
degradation and consequent loss of expression (Kang et al. 2009, Walgren and Mcleod 
2005). The Wells laboratory has designed lentiviruses encoding short hairpin (sh) RNAs 
designed against the mRNA transcripts encoding AmotL1 or a negative control “Scramble” 
sequence, which would identify any potential effects of the infection process itself. Once 
target cells are infected, the virus incorporates itself into the host genome and begins both 
Figure 4: Overexpression of Cx43 protein by hEAT Cx43 
Untagged cell lines. Western blot analysis reveals a 25-fold 
increase in Cx43 protein in hEAT Cx43 Untagged cells relative 
to control hEAT cells.  
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replication and transcription of viral shRNA transcripts. As these double-stranded shRNAs 
are produced and released into the cytoplasm, the endoribonuclease Dicer soon cleaves 
them into small-interfering (si) RNA molecules of about 21-23 nucleotides in length. Upon 
facilitated activation by Dicer, the RNA-induced silencing complex (RISC) component, 
Argonaute or Slicer, incorporates an unwound single-stranded siRNA as a guide strand 
while degrading the complementary passenger strand (Hammond 2005). RISC utilizes this 
guide strand to identify and specifically bind a target mRNA transcript via complementary 
base pairing. Once bound, Argonaute is activated and cleaves the host mRNA transcript; 
thereby preventing gene expression and protein translation (Ambesajir et al. 2012, Kim 
and Rossi 2008). 
hEAT Cx43 Untagged cells were transduced with lentiviral RNAi against AmotL1. 
Western blot analysis validated the overexpression of Cx43 versus control cells (Figure 
5B-C). As shown in the immunoblot, AmotL1 knockdown resulted in a significant 
reduction (~70%) in AmotL1 protein thus validating the efficiency of knockdown. 
Consistent with RNA-seq data conducted previously by the Wells laboratory (Figure 1 in 
the Introduction), a loss of AmotL1 is accompanied by a significant reduction (~90%) in 
Cx43 protein expression (Figure 5C). Cx43 and AmotL1 levels were normalized to either 
GAP-DH and -Tubulin controls, respectively. I then sought to validate my prediction that 
a reduction in Cx43 would result in less Cx43 at cell-cell junctions. 
After growing cells on acid-washed coverslips for 60 hours, nuclei were stained 
with Hoechst dye, a polyclonal Cx43 antibody with emission at 594 nm, and a monoclonal 
ZO-1 antibody with emission at 488 nm. As discussed in the Introduction, ZO-1 was used 
to mark cell peripheries and to look for colocalization with Cx43 at gap junctions. I 
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predicted that a loss of Cx43 would result in reduced gap junction formation and cell-cell 
cohesion. These observations may support the mesenchymal morphologies and apparent 
invasiveness associated with AmotL1-knockdown astrocytes grown in three-dimensional 
culture (Figure 3). Remarkably, the opposite of my prediction of reduced Cx43 at junctions 
was observed. 
Figure 5: AmotL1 knockdown through RNAi causes a reduction in Cx43 expression but increases Cx43 
localization to cellular junctions. A. Localization of Cx43 and ZO-1 in hEAT Cx43 Untagged cells by 
lentiviral treatment. Upon shAmotL1 RNAi, the relative concentration of Cx43 to cell-cell contacts and 
peripheries increase relative to control cells. B. Western blot analysis reveals a 70% knockdown of AmotL1 
relative to uninfected hEAT Cx43 Untagged cells. C. Knockdown of AmotL1 results in an 85% reduction in 
Cx43 in hEAT Cx43 Untagged cells. Uninfected control hEAT cells are included to validate overexpression 
of Cx43 in hEAT Cx43 Untagged cells in this experiment. 
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Upon knockdown of AmotL1, there was a noticeable shift in the distribution of 
Cx43 from the cytosol to both the cell cortex, presumably for hemichannel formation, and 
to cell-cell contacts (Figure 5A). To validate this observation, nine microscopic fields from 
each treatment group were randomly selected for imaging based only on nuclei density and 
positioning. Healthy cells that made clear contacts with adjacent cells without stacking or 
climbing on top of one another were desired. Upon viewing the 488 nm and 594 channels, 
if a field revealed no cell-cell contacts or if the cells appeared to be physically damaged by 
the fixation procedure, a new field was randomly selected by nuclei once again. To reduce 
bias, images were anonymously labeled, shuffled and two weeks of time were allowed to 
pass before gap junctions were identified for quantification. Independent sites where both 
Cx43 and ZO-1 colocalized at cell-cell contacts were counted. To take into consideration 
the slight variations in cell densities between images, this number was divided by the total 
number of nuclei of adjoining cells present in the microscopic field. If a cell was not in 
contact with any other cell in the field, its nucleus was not included in this count. 
I then calculated colocalization score ratios, abbreviated as CS, of ZO1-Cx43 
colocalization sites at cell-cell contacts to the appropriate number of adjoining nuclei in 
each field (Table 1). When plotted into box and whisker plots, these scores present a trend. 
Shown in Figure 6, both normal hEAT and hEAT Cx43 Untagged cells treated with RNAi 
against AmotL1 experience increased colocalization compared to their respective control 
groups, uninfected or infection with shScramble-encoding lentivirus. Single-factor analysis 
of variance and post-hoc tests (not shown) indicate that shAmotL1-treated cells had a mean 
CS significantly higher than uninfected group in normal hEAT cells (p<0.002). In the 
Cx43-overexpressing cell line, there was no significant difference between uninfected 
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 cells and cells experiencing RNAi against AmotL1; however, the shScramble-treated cells 
had a significantly lower mean score compared to those treated with shAmotL1 (p=0.027). 
In the rightmost graph, cell types were condensed based on treatment (N=18 fields). It is 
clear that AmotL1 knockdown results in an increased distribution of Cx43 to cell-cell 
contacts as well as enhanced colocalization with ZO-1 at these sites. Taken together, these 
data suggest that AmotL1 plays a pivotal role in limiting gap junction formation.  Despite 
the significant reduction in Cx43 protein expression, a knockdown of AmotL1 appears to 
increase the formation of gap junctions in human embryonic astrocytes. In many cases, 
well-defined gap junctions were observed in AmotL1-knockdown cells and appear as 
punctate structures running perpendicular to the plasma membrane at cell-cell contacts. 
Figure 6: Quantification of Cx43–ZO-1 colocalization. A. Boxplots of colocalization scores, CS (CS = 
number of sites where there is colocalization of Cx43 and ZO-1 at cell-cell contacts : number of independent 
nuclei that are in adjoining cells within the field of vision). Both control hEAT cells and hEAT Cx43 
Untagged cells experience greater colocalization of Cx43 and ZO-1 to junctions upon AmotL1 knockdown. 
N=9 fields per group. 
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After extensive imaging and optimization, I felt that control hEAT cells expressing 
endogenous Cx43 present better gap junction formation compared to hEAT Cx43 
Untagged cells. Therefore, only they are used for further analysis. In Appendix B, I have 
included multiple images for each cell type and treatment for comparison (Figures 13-15). 
Next, I sought to explore the effects of cellular differentiation on gap junction formation. 
Embryonic hEAT cells exist in a naturally undifferentiated, pluripotent state. After 
lentiviral infection or not, cells were subjected to 60 hours of growth in Barris Neurobasal 
media (see Cell Culture in the Methods) before fixation. This conditioned media has an 
abundance of supplements including those of the B-27 category, a widely-used and trusted 
product in neuronal cell culture (ThermoFischer Scientific). Although the mechanism by 
which this media induces commitment is still unclear, it is believed that growth factors and 
other signaling molecules may function through pathways similar to TGF, Wnt, 
Hedgehog and insulin-like growth factor receptor pathways to stimulate terminal 
differentiation in embryonic astrocytes (Dhara and Stice 2008). 
As previously observed, RNAi against AmotL1 leads to increases in the relative 
concentrations of Cx43 and ZO-1 at gap junctions, cell-cell contacts, and peripheries 
compared to control treatments. Remarkably, however, the addition of Barris neurobasal 
media stimulates extensive localization to junctions in cells across all treatments (Figure 
7). These data suggest that a loss of AmotL1 may mimic or induce the effects of 
differentiation. It may also be that AmotL1 protein is lost in differentiated cells, leading to 
the increased formation of intercellular gap junctions despite reductions in Cx43 protein. 
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Ultimately, these observations were counterintuitive and I feel that further 
investigation will be warranted in the future to better understand these mechanisms. 
Consistently throughout these experiments, cell flattening is observed upon knockdown of 
AmotL1. This suggests that cytoskeletal components may be affected by the changing 
Table 1: Single-factor ANOVA statistical analysis of Cx43–ZO-1 colocalization scores, CS. A. Analysis of 
CS in control hEAT cells. Post-hoc tests (not included) reveal that the mean CS for hEAT shAmotL1-treated 
cells is significantly higher than that of the two control groups. B. Analysis of CS in hEAT Cx43 Untagged 
cells. hEAT Cx43 Untagged shAmotL1-treated cells have a mean CS that is statistically higher than that of 
the hEAT Cx43 Untagged shScramble-treated cells, but not that of uninfected cells. C. Analysis of CS in 
combined cell types (control hEAT and hEAT Cx43 Untagged) based solely on treatment alone. Post-hoc 
analysis reveals that a knockdown of AmotL1 results in statistically higher mean CS. 
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levels of AmotL1 through RNAi. Taken together, I chose to investigate the effects of 
AmotL1 expression changes on cytoskeletal actin dynamics.  
Future directions regarding Cx43 
I had predicted that as Cx43 expression decreases following AmotL1 knockdown, cells 
would lose Cx43 at gap junctions and the associated intercellular communication; however, 
my observations regarding Cx43 localization to gap junctions were contradictory to these 
preconceived beliefs. It may prove insightful to further investigate the phenomena that has 
been observed. Unfortunately, I feared that this project would not yield satisfactory 
findings during my limited time in Indianapolis. It was therefore essential that I progress 
to other experiments for my Masters research.  
As discussed, a significant shift in the distribution of Cx43 from the cytoplasm to 
the plasma membrane occurs upon knockdown of AmotL1. I hypothesize that this may be 
due to some inhibitory interaction that exists between Cx43 and AmotL1. It is possible that 
AmotL1 binds Cx43 and prevents its trafficking to the membrane. Upon RNAi against 
AmotL1, Cx43 may exist free of these interactions and be able to travel. To my knowledge 
there have not been any publications regarding the physical interaction between AmotL1 
and Cx43. I would suggest co-immunoprecipitation assays be conducted to validate how 
these two proteins interact. By creating mutations in bait AmotL1 at a variety of sites and 
subjecting them to an abundance of prey Cx43 protein lysate, the residues on AmotL1 
required for this interaction may be identified. An additional co-immunoprecipitation assay 
could be conducted in which Cx43 residues are mutated and exposed to purified AmotL1. 
Taken together, these experiments could potentially identify the domains specific amino- 
acid residues required for this protein-protein interaction to occur.  
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Figure 7: Cx43 and ZO-1 localization in undifferentiated and differentiated hEAT cells upon treatment. A. 
Cells grown in standard DMEM complete for hEATs. Upon knockdown of AmotL1, cells experience 
increased gap junction formation, suggested by the colocalization of Cx43 and ZO-1 to cell-cell contacts. B. 
Western blot analysis for cells shown in A, indicating successful AmotL1 knockdown via RNAi. C. Cells 
grown in Barris Neurobasal media. Differentiation increases gap junction formation and Cx43 localization to 
cell-cell contacts. D. Western blot analysis for cells shown in C 
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Throughout the literature a majority of proteins bind the carboxyl-terminal domain 
of Cx43; however, this is because they interact with Cx43 when it is localized to the plasma 
membrane, often for scaffolding purposes. Throughout my imaging, I have observed an 
abundance of cytoplasmic Cx43, which may be interacting with AmotL1. Unfortunately, I 
was unable to stain both proteins simultaneously for immunofluorescent imaging since the 
Wells laboratory only possessed polyclonal antibodies against both. In the future, the lab 
could attempt to purchase and optimize a more specific monoclonal antibody for Cx43. 
Additionally, immunofluorescent imaging could be conducted on cells that produce a 
fluorescently-labeled AmotL1 or Cx43 protein. In later experiments, I generated hEAT 
cells labeled with a YFP-labelled AmotL1 that could be used for this purpose (see Methods 
for appropriate protocols). 
I failed to explore the reasons for reduced Cx43 protein expression upon AmotL1 
knockdown. There may be several reasons why cells experience this change. As may be 
supported by a co-immunoprecipitation assay, the binding of AmotL1 to Cx43 may serve 
as a protective mechanism prohibiting both the translocation of Cx43 and its degradation. 
The protein-protein interaction may prevent Cx43 trafficking to the lysosome or it may 
inhibit the ubiquitination of Cx43 by E3 ubiquitin ligases, thus protecting it from 26S 
proteasomal degradation. When cells experience RNAi and knockdown of AmotL1, Cx43 
may lose this protective partner and experience the increased degradation as a potential 
explanation to the results seen in the Western blot of Figure 5C.  
Consistent with the RNA-seq data (Figure 1), AmotL1 may influence the 
transcription of Cx43. It is known that AmotL1 regulates YAP/TAZ transcriptional co-
activators and that a loss of AmotL1 allows these transcription factors to translocate into 
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the nucleus and induce expression of pro-growth, often oncogenic, genes (Chan et al. 2011, 
Zanconato et al. 2016). To explain the changes in Cx43 transcript levels seen in both patient 
sample data and in the AmotL1-silenced hEAT cells generated by the Wells laboratory, 
further investigation will be required. Although changes in Cx43 mRNA levels correlate 
with loss of AmotL1, connexin expression may be regulated by epigenetic mechanisms. 
Under consideration that 2-HG accumulates in lower grade gliomas and may promote 
secondary GBM, excessive hypermethylation of DNA may prevent expression of Cx43 
(Oyamada et al. 2012). 
Additionally, I did not conduct any functional assays to determine the effects of 
Cx43 localization to cell-cell contacts upon knockdown of AmotL1. Although the imaging 
revealed an increase in the formation of gap junctions upon both RNAi against AmotL1 
and differentiation, a dye transfer assay could serve as a definitive measure of GJIC (Babica 
et al. 2016). Future experiments could generate an acceptor cell line that fluoresces an 
identifier protein. As mentioned, I have successfully expressed a YFP-labeled AmotL1 in 
hEAT cells which could serve this purpose in addition to its use in AmotL1-Cx43 
colocalization studies. A fluorescent dye could then be added to a non-fluorescent donor 
cell population for uptake.  
If using YFP-labelled AmotL1 in hEAT cells, Lucifer Yellow with emission at 594 
nm may be an ideal dye. Once the donor cells appear to have received the dye, the two cell 
populations could be mixed evenly onto a new plate. After allowing a suitable time for the 
formation of gap junction (60 hours if seeding 200,000 cells of each population onto 
coverslips), cells could either be live-imaged or fixed for imaging. Using microscopy, the 
number of fluorescent acceptor cells that have taken in the dye could be quantified and 
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compared across the three treatment groups: uninfected, shScramble and shAmotL1. It is 
vital that the acceptor population be fluorescently labeled since fluorescence may be lost 
over time or incorporation by the lentivirus may not be completely efficient. If one were to 
add the fluorescent dye to fluorescent donor cells, these cells may lose their protein 
fluorescence without having transferred the dye to a non-fluorescent acceptor cell, giving 
the false illusion that an acceptor cell received dye from a donor through GJIC. 
It may even be worthwhile to investigate the effects of changing AmotL1 levels on 
hemichannel activity. Upon both knockdown of AmotL1 and differentiation, astrocytes 
experience increases in Cx43 localization to cell peripheries which may be indicative of 
hemichannel formation that allows for the molecular transport between the cellular cytosol 
and the ECM. RNAi-treated and untreated cells could be seeded and subjected to the 
addition of ethidium bromide (EtBr) directly to their growth media. EtBr is a fluorescent 
dye that enters cells only through functional hemichannels. Once inside, it can translocate 
into the nucleus, intercalate itself within DNA and fluoresce (Schadzek et al. 2018). Cells 
containing dye could either be imaged and counted, or they could be subjected to flow 
cytometry for quantification of entire cell populations. Functional assays to determine how 
a loss of AmotL1 affects cell-cell communication will certainly provide key insight into 
the mechanisms promoting carcinogenesis. Should these experiments yield novel results, 
the clinical implications may offer life-changing benefits to both the patient and scientific 
communities. 
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AmotL1 knockdown appears to influence actin dynamics, resulting in a loss of stress fibers 
and focally-localized actin. 
Throughout these experiments, I consistently observe that AmotL1 knockdown causes 
cells to experience reduced proliferation in culture. I have attempted to quantify this 
observation using an MTT assay but to no avail. This technique utilizes NADPH-dependent 
oxidoreductases to reduce tetrazolium MTT dye and serves as a measure of mitochondrial 
activity. As the number of cells increases, there is increased reduction of MTT detectable 
by spectrophotometry. Seeding at 20,000 cells per well of a 96-well plate, I found that cells 
began to clump together and die after two days of growth. In future studies I would suggest 
seeding at 10,000 cells per well. 
In addition to decreased proliferation, knockdown of AmotL1 through RNAi leads 
to cell flattening. Affected cells appear larger than control cells and are rounder and more 
pancake-like in their morphology (see Figure 8). To help explain these trends, I 
investigated changes in the actin cytoskeleton, as this serves to guide both cellular 
morphology and establish polarity. 
Using phalloidin as a red fluorescent dye that stains filamentous F-actin, both 
control cells and those treated with RNAi against AmotL1 were imaged. Results are shown 
in Figure 9. Since RNAi is not 100% efficient across all treated cells, AmotL1 was also 
stained with the intention of visually identifying cells with differential knockdown of the 
protein. This could allow for the selection of a field of view that contains cells with normal 
or reduced AmotL1 expression and compare changes in actin organization. I had predicted 
that as these astrocytes flatten, they would experience greater adhesion to any extracellular 
surfaces. This could be validated by general increases in the amount of focal adhesions, 
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which appear as speckles near the cell body, as well as increased stress fiber formation. 
However, the opposite effect was observed upon imaging. Flattened cells with successful 
AmotL1 knockdown had notably less focally-localized actin, less stress fibers and an 
increase in cortical actin. 
Previous work conducted by the Wells laboratory has identified similar changes in 
actin organization depending on LATS1/2 (Large Tumor Suppressor Protein 1/2) kinase 
activity and the phosphorylation status of Angiomotin-protein-130 (Amot-p130). Cells 
with low expression of Amot-p130 are characterized by high LATS activity. In MCF7 
breast cancer cells, it appears that LATS phosphorylates Amot-p130, causing a shift in the 
distribution of actin from active stress fibers to the cellular cortices. Likewise, exogenous 
expression of Amot1p-30 causes an inverse reduction in LATS activity. This event is 
followed by visual increases in the formation of stress fibers and focally-localized actin 
attachments to the ECM due to the dephosphorylated status of Amot-p130 (unpublished 
data). I have essentially repeated these observations in human embryonic astrocytes. With 
reduced AmotL1 levels and phosphorylation in cells, these conditions promote stress 
fibers. Furthermore, to identify the effects of differentiation on cytoskeletal arrangements, 
cells were raised in Barris Neurobasal media. I predicted that differentiation would lead to 
increases in LATS activity, which is consistent with previous findings in the Wells 
laboratory. If true, high LATS activity and phosphorylation of AmotL1 would increase the 
relative concentration of cortical actin. Shown in Figure 8C, similar actin patterns are 
observed only in the AmotL1-knockdown cells.  
As these cells flatten, they lose stress fibers, focally-localized actin and develop a 
band of cortical actin around their peripheries. Uninfected cells and cells treated with the 
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Figure 8: Actin cytoskeletal changes in hEAT cells upon differentiation and treatment. A. Cells grown in 
standard DMEM complete for hEATs. Upon AmotL1 knockdown, cells become significantly rounded and 
experience losses in both stress fibers and focally-localized actin. Instead these cells experience increases in 
their distribution of cortical actin. B. Western blot analysis for cells shown in A. C. Cells grown in Barris 
Neurobasal media. Even in the presence of pro-differentiation signals, AmotL1 knockdown causes a 
reduction in the formation of stress fibers. D. Western blot analysis for cells shown in C.  
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shScramble lentiviral RNAi continue to exhibit stress fibers, indicating that AmotL1 may 
be playing an even more critical role in regulating actin dynamics than has been previously 
considered. Other conditions were investigated, in which combinations of ZO-1 and actin, 
well-established binding partners, and AmotL1 and ZO-1 were stained to see if there is any 
form of colocalization that may be indicative of a binding interaction. Like previous 
findings, I repeatedly observe increased distribution of ZO-1 to cell peripheries and 
contacts upon AmotL1 knockdown, as well as upon differentiation using Barris Neurobasal 
media (See Figures 11-12, in Appendix A). 
To explain these phenomena, I hypothesize that AmotL1 may be influencing the 
activity of RhoA GTPase which stimulates the formation of filamentous actin (e.g. stress 
fibers). Unphosphorylated AmotL1 may indirectly activate RhoA through the stimulation 
of Syx protein. Syx, also named TECH or PLEKHG5, is a RhoA-specific synectin-binding 
guanine exchange factor that is localized to cellular membranes through its interaction with 
the Crumbs polarity complex. Upon binding, Syx activates RhoA through an exchange of 
GTP for its bound GDP (Dachsel et al. 2013). Upon binding to GTP, RhoA undergoes a 
conformation change to become active (Truebestein et al. 2015). It may then interact with 
ROCK1 (Rho-associated, coiled-coil-containing kinase) or Cdc42 (Cell division control 
protein 42 homolog) to induce downstream activation of actin nucleators (Azab et al. 2009, 
Watson et al. 2011, Maekawa 2009, Maekawa 1999, Tapon et al. 1997). These nucleators 
include mDiA1/2 which allow for the formation of new stress fibers throughout the 
cytoskeleton, and the Arp2/3 (actin-related protein 2/3) complex which is activated upon 
binding by WASP (Wiskott–Aldrich syndrome protein) members, respectively (Padrick et 
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al. 2011). Active Arp2/3 may then bind the sides of filamentous F-actin and stimulate 
nucleation of branched actin fiber formation.  
To investigate these principles, I utilized lentiviruses to induce expression of 
exogenous AmotL1 WT, AmotL1 S262D, or AmotL1 262A mutants in both hEAT and 
A172 human glioblastoma cell lines. The WT was used as a control and mutants were 
utilized to investigate the role of AmotL1 phosphorylation status on stress fiber formation. 
Both constructs were designed by the Wells laboratory prior to my entry. The S262D 
mutant has been designed to mimic a phosphorylated state. I predicted that cells expressing 
this mutant would be less able to activate RhoA, thus cells would have reduced amounts 
of stress fibers. Under these conditions, I anticipated that this would lead to the 
development of a cortical actin band as seen in the AmotL1-knockdown cells of Figure 8. 
Likewise, the S262A mutant was designed to prevent phosphorylation of AmotL1, thus 
promoting its activation of RhoA via Syx and allowing for the formation of new stress 
fibers.  
As an additional factor I did or did not overexpress Nedd4-1, a HECT-domain-
containing member of the AIP4 E3 ubiquitin ligase family. Previous studies have suggested 
that phosphorylated AmotL1, similar to angiomotins, can activate Nedd4-1 (Wang et al. 
2012). Active members of the AIP4 family, such as Smurf1, can ubiquitinate and lead to 
the degradation of both RhoA and AmotL1 as a form of negative feedback (Wang et al. 
2006, Bryan et al. 2005). Thus, I predicted that cells expressing the AmotL1 S262D mutant 
and Nedd4-1 would lead to increased degradation of RhoA, resulting in a loss of stress 
fibers because of its inability to activate mDIA1/2, WASP/WAVE and Arp2/3 complexes 
needed for actin nucleation. 
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Figure 9: Effects of AmotL1 phosphorylation status and possible ubiquitination on actin organization in 
hEAT cells. An AmotL1 262D mutant, upon Nedd4-1 expression, results in reduced stress fiber 
formation. Upon expression of Nedd4-1, there is a colocalization of Nedd4-1 and AmotL1 within the 
nucleus. 
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In hEAT cells, many of these predictions were validated by my results (See Figure 
9). Cells treated with a control empty vector and AmotL1 WT conditions, with or without 
the addition of Nedd4-1, present abundant stress fibers and focal adhesions throughout the 
cell body. When cells express the AmotL1 S262D mutant, they continue to exhibit stress 
fiber formation despite their irreversible phosphorylation status. Upon the expression of 
Nedd4-1, however, there is a significant change in the cytoskeletal actin arrangement of 
these mutant cells. There is reduced stress fiber formation and the presence of focal 
adhesion-like speckles near the cell body. These observations suggest that AmotL1 
phosphorylation can influence actin cytoskeletal arrangements in a Nedd4-1-dependent 
manner. It may be that Nedd4-1 requires the activation from phosphorylated AmotL1 to 
ubiquitinate and degrade RhoA via the 26S proteasome; however, the interactions and 
molecular mechanism warrant further investigation to elucidate the definitive roles of each 
protein. Cells expressing the AmotL1 S262A mutant, which prevents AmotL1 
phosphorylation and Nedd4-1 activity, remain abundant with stress fibers and the 
production of exogenous Nedd4-1 appears to have no impact on actin. This is likely due to 
the Nedd4-1 dysfunction brought about by the AmotL1 mutation. 
Upon expression of Nedd4-1 in both hEAT and A172 cells (Figures 9 and 10), 
AmotL1 and Nedd4-1 to consistently colocalize punctate regions within the cell body that 
appear to be nuclear. This is highly interesting, as there is limited evidence proposing the 
translocation of AmotL1 into the nucleus although it can promote the transcription of 
certain genes. Taken together, this observation suggests that this may be a novel finding. 
Related angiomotins have been shown to exist in the nucleus and studies suggest that 
translocation may require sumoylation and binding to importins (Zhu et al. 2017). 
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However, AmotL1 has an arginine residue within its nuclear localization sequence 
preventing sumoylation. This suggests that a different post-translational modification is 
required for import, such as ubiquitination. 
Of course, I am limited in making these claims. I did not include a nuclear dye 
within the immunofluorescent procedure for these experiments due to my choices in 
fluorescently-labeled proteins and phalloidin stain. I intend on repeating this experiment 
using the YFP-labelled AmotL1 variations, the CFP-labelled Nedd4-1 and propidium 
iodide for nuclear staining in order to validate the localization of AmotL1 to the nucleus. 
Since translocation occurs only in the presence of Nedd4-1, it seems that ubiquitination of 
AmotL1 by this E3 ligase is essential. In the future, it would be interesting to generate cells 
that express an AmotL1 K488R mutant that prevents its ubiquitination. I predict that this 
site-directed mutagenesis will prevent Nedd4-1 from acting on AmotL1, thus preventing 
its translocation into the nucleus. 
Future studies should investigate expression of RhoA, and other proteins proposed 
by my model, upon changing experimental conditions. Cells could be infected to express 
AmotL1 S262D alone, Nedd4-1 alone or combined and Western blot analysis used to 
quantify RhoA protein levels. I expect RhoA to have higher expression in both single 
treatments; however, upon combination, I anticipate that the phosphorylated AmotL1 
would activate Nedd4-1, leading to the ubiquitination and proteasomal degradation of 
RhoA, resulting in less protein on the immunoblot. These data, if true, would further 
validate the observation of decreased stress fiber formation seen in AmotL1- knockdown 
cells. Should these results indicate that RhoA protein is affected, it may prove beneficial 
to explore its degradation. Cells could be treated with cycloheximide to block new RhoA  
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Figure 10: Effects of AmotL1 phosphorylation status and possible ubiquitination on actin organization in 
A172 cells. GBM cells differ in actin organization compared to control hEAT cells. Upon expression of 
Nedd4-1, there is a colocalization of Nedd4-1 and AmotL1 within the nucleus. It appears that the AmotL1 
262D mutant as well as the AmotL1 wildtype upon expression of NEDD4-1 stimulates formation of 
filipodia. 
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translation, then the degradation of remaining pre-existent RhoA could be tracked overtime 
amongst the different treatment groups. I would also like to better understand the 
mechanism by which RhoA is targeted for proteasomal degradation (Wei et al. 2013, Wang 
et al. 2006, Bryan et al. 2005). Using K7, K48, and K63 ubiquitin mutants, the amino acid 
residues and branching patterns required for the degradation of RhoA could be identified 
(Ohtake et al. 2018). 
These experiments have allowed me to define the effects of expressing AmotL1 or 
its mutants that mimic various phosphorylation statuses at serine 262 by the LATS1/2 
kinases. This has allowed for the validation of previous findings made by the Wells 
laboratory. By combining these conditions with exogenous expression of the NEDD4-1 E3 
ubiquitin ligase, my data suggest that ubiquitination of AmotL1 may be more important 
that previously considered. This post-translational modification is responsible for both the 
regulation of AmotL1 phosphorylation status and the potential translocation of AmotL1 
into the nucleus. Expression of an AmotL1 S262D mutant in combination with NEDD4-1 
results in a profound loss of actin stress fibers, likely due to the degradation of filamentous 
actin-promoting proteins which I currently believe is RhoA. Taken together, these data 
create a story in which AmotL1 is a central player in guiding cell behavior. In addition to 
its known roles in preventing oncogenic expression via regulation of YAP/TAZ, I have 
shown that AmotL1 expression and phosphorylation status act to dictate cell morphology 
by regulating the dynamics of the actin cytoskeleton. Changes in polarity and architecture 
may have consequences that have not yet been thoroughly investigated, especially in the 
context of GBM. These properties make AmotL1 a novel therapeutic target in 
understanding the mechanisms of carcinogenesis and in the global combat against cancer. 
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Figure A-11: Changes in actin cytoskeletal arrangements and colocalization with ZO-1 in hEAT cells 
upon differentiation and treatment. A. Cells grown in standard DMEM complete for hEATs. Upon 
knockdown of AmotL1, cells become rounded, lose stress fibers and focally-localized actin yet 
experience increased distribution of cortical actin. In the shAmotL1 images, it appears that 2/3 cells 
have AmotL1 knockdown; the third continues to demonstrate stress fiber formation. B. Western blot 
analysis for cells shown in A. C. Despite growth in Neurobasal media, cells with AmotL1 knockdown 
have reduced stress fiber formation. D. Western blot analysis for cells shown in C. 
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Figure A-12: AmotL1 and ZO-1 colocalization in hEAT cells upon differentiation and treatment. A. 
Cells grown in standard DMEM complete for hEATs. Upon AmotL1 knockdown, cells become rounded 
and experience increased cortical localization of ZO-1. This is indicative of increased gap junction 
formation. B. Western blot analysis for cells shown in A indicates 40% knockdown of AmotL1. C. Cells 
grown in Barris Neurobasal meida. Differentiation increases the relative abundance of ZO-1 to cell-cell 
contacts, presumably at gap junctions. D. Western blot analysis for cells shown in C shows successful 
AmotL1 knockdown by RNAi. 
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Figure A-13: Cx43 and ZO-1 colocalization in uninfected cells. A. Colocalization in control hEAT cells. 
B. Colocalization in hEAT Cx43 Untagged cells. 
 
A. 
B. 
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Figure A-14: Cx43 and ZO-1 colocalization in shScramble-treated cells. A. Colocalization in control hEAT 
cells. B. Colocalization in hEAT Cx43 Untagged cells. 
A. 
B. 
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 Figure A-15: Cx43 and ZO-1 colocalization in shAmotL1-treated cells. A. Colocalization in control hEAT 
cells. B. Colocalization in hEAT Cx43 Untagged cells. 
A. 
B. 
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Figure A-16: Preliminary exploration of the effects of AmotL1 phosphorylation status              
and ubiquitination on actin cytoskeletal organization in hEAT cells. ZO-1 was stained with 
a monoclonal ZO-1 antibody with emission at 488 nm which conflicted with YFP-AmotL1. 
AmotL1 / 
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AmotL1 / 
Figure A-17: Preliminary exploration of the effects of AmotL1 phosphorylation status              
and ubiquitination on actin cytoskeletal organization in A172 cells. ZO-1 was stained with a 
monoclonal ZO-1 antibody with emission at 488 nm which conflicted with YFP-AmotL1. 
AmotL1 262D mutants have extensive filopodia. 
48 
Appendix B 
Figure B-18: Optimization of Cx43 antibodies. 
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Figure B-19: Optimization of AmotL1 antibody. Made in house by the Wells laboratory. 
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Figure B-20: Optimization of ZO-1 and -Tubulin antibodies. A. Attempted ZO-1 antibody 
dilutions. B. Attempted -Tubulin antibody dilutions. 
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Figure B-21: Optimization of Lamp1 and Arf6 antibodies. A. Attempted Lamp1 antibody 
dilutions. B. Attempted Arf6 antibody dilutions. 
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Figure B-22: Optimization of phalloidin. 
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